Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revolving credit borrowings	$ (1,450,000)	$ 0
Proceeds from Issuance or Sale of Equity	$ 3,065,941	0
Document Period End Date	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (1,316,833)	(1,302,009)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	56,316	128,695
Amortization of Other Deferred Charges	59,416	0
Stock compensation expense	6,911	12,399
Change in assets and liabilities:
Accounts receivable, net	(1,213,497)	1,296,548
Inventories	(48,808)	(312,261)
Prepaid expenses and other current assets	234,930	62,766
Other assets	(16,744)	25,526
Accounts payable	542,426	676,549
Accrued compensation and employee benefits	144,809	78,803
Accrued expenses	39,001	(146,777)
Unearned revenue	(61,639)	64,301
Other liabilities	24,071	(6,520)
Net cash provided by (used in)	(1,549,641)	578,020
Cash flows from investing activities:
Increase (Decrease) in Trading Securities	(95)	(165)
Payments to Acquire Property, Plant, and Equipment	(19,513)	(42,605)
Net Cash Provided by (Used in) Investing Activities	(19,608)	(42,770)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Net Cash Provided by (Used in) Financing Activities	1,615,941	0
Effect of Exchange Rate on Cash and Cash Equivalents	(6,789)	279,450
Cash and Cash Equivalents, Period Increase (Decrease)	39,903	814,700
Cash at beginning of year	2,253,952	1,954,422
Cash at end of period	$ 2,293,855	$ 2,769,122